Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1997

View Archived Issues

French researcher discloses preventive effects of tryptamine derivatives

New approach to obesity gene research at Lilly

New topoisomerase I inhibitors synthesized at Rutgers

Dual TNF/PDE IV inhibitors described by Chiroscience

Allergan claims retinoid-like compounds

NO donors claimed by Searle for cardiovascular applications

MRC scientists investigate role of somatostatin receptors in the CNS

French investigators announce success of gene therapy for CF

Millennium/Roche obesity collaboration results in another significant discovery

AutoImmune initiates clinical trials in transplant rejection

Gene therapy for AIDS to enter clinical testing in U.S.

Betafectin clinical update

Chemopreventive properties of resveratrol publicized

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Bio-Technology General's OxSODrol tested for safety and efficacy

Schering-Plough selects Corvas thrombin inhibitor for development

OXIS files IND for BXT-51072

Biopool enters option agreement for assay technology

Cell Genesys signs cancer gene therapy R&D collaborations

NeXstar reveals new oligonucleotide synthesis method

Palatin, Nihon Medi-Physics forge licensing agreement for diagnostics

Biometric Imaging and Immucor sign marketing agreement

Ventus progressing well in phase III

TLC ELL-12 in toxicology testing

Viracept expanded access program broadened

Update on Cypros' CPC-211 and CPC-111

Positive phase III results reported for SCF

The Liposome Company's Abelcet receives marketing approval in 14th country

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...